Comparison
2q23 1 Microduplication Syndrome vs 1 4 Toe Syndactyly C4023725
Clinical comparison between 2q23 1 Microduplication Syndrome and 1 4 Toe Syndactyly for differential diagnosis and treatment planning.
6 comparison axes
Onset
2q23 1 Microduplication Syndrome
0-5
1 4 Toe Syndactyly C4023725
0-0
Onset patterns differ
Severity
2q23 1 Microduplication Syndrome
severe
1 4 Toe Syndactyly C4023725
mild
Different severity levels
Chronic
2q23 1 Microduplication Syndrome
Chronic
1 4 Toe Syndactyly C4023725
Chronic
Differing course
Communicable
2q23 1 Microduplication Syndrome
No
1 4 Toe Syndactyly C4023725
No
Different transmission
Body System
2q23 1 Microduplication Syndrome
congenital
1 4 Toe Syndactyly C4023725
musculoskeletal
Same/different system
Category
2q23 1 Microduplication Syndrome
rare-disease
1 4 Toe Syndactyly C4023725
genetic
Different category
Bottom line
2q23-1-microduplication-syndrome-C4707847 and 1-4-toe-syndactyly-C4023725 differ in severity, etiology
Key differentiating points
Findings that most reliably separate the two conditions at the bedside or in the workup.
| Feature | 2q23 1 Microduplication Syndrome | 1 4 Toe Syndactyly C4023725 | Discriminating power |
|---|---|---|---|
| Overall presentation | Labeled severe and congenital; specific features are not established in the supplied data. | Mild skin joining of the first and fourth toes, often both feet. | High |
| Functional impact | Potential broader developmental or medical effects are not defined here. | Usually limited to the feet and may not impair walking. | Moderate |
| Onset | Reported onset range is early childhood, ages 0-5. | Present at birth according to the supplied onset axis. | Moderate |
When to favor each condition
Choose 2q23 1 Microduplication Syndrome when
A rare chromosomal diagnosis is being considered
The left concept is categorized as a rare congenital condition rather than an isolated toe finding.
Moderate
Severity is described as severe
The supplied severity axis assigns severe to the left and mild to the right.
Moderate
Genetic confirmation is required
A named microduplication implies chromosomal testing, but exact criteria are not supplied.
Low
Choose 1 4 Toe Syndactyly C4023725 when
Only first-and-fourth toe skin joining is described
This matches the supplied description of 1-4 toe syndactyly.
High
Walking is unaffected
The source states treatment is often unnecessary when walking is not impaired.
Moderate
No broader congenital syndrome is documented
An isolated mild musculoskeletal finding should not be equated with the left syndrome.
Moderate
How key tests differ
| Test | 2q23 1 Microduplication Syndrome | 1 4 Toe Syndactyly C4023725 | Interpretation |
|---|---|---|---|
| Clinical foot examination | No specific foot finding is established by the supplied data. | Visible skin connection between the first and fourth toes. | Supports the right finding but does not diagnose the left syndrome. |
| Chromosomal microarray | Could be relevant to a microduplication, but expected result details are not supplied. | Not required for an isolated mild toe finding based on supplied data. | Testing decisions require clinician interpretation. |
| Gait assessment | Functional effects are not established here. | Often normal; impairment would warrant reassessment. | Abnormal gait is a finding, not by itself a syndrome diagnosis. |
Prognosis comparison
2q23 1 Microduplication Syndrome
- Outcome
- Prognosis is not established from the supplied data.
- Factors
- Severity is labeled severe, but outcome factors are unspecified.
1 4 Toe Syndactyly C4023725
- Outcome
- Often benign when walking remains unimpaired.
- Factors
- Foot function and any associated findings matter.
Time frame: Both are described as chronic congenital conditions; exact timelines are unavailable.
Clinician interpretation is needed because source evidence is sparse.
Complications comparison
| Complication | Presentation |
|---|---|
| Walking difficulty | Not established from the supplied source. May occur, but the source says walking is often unimpaired. Functional assessment should guide concern. |
| Broader medical complications | Possible given severe rare-disease labeling, but unspecified. No systemic complications are described. Do not infer complications without clinical evidence. |
| Need for intervention | Management needs are not established. Often none if function is preserved. Intervention decisions belong to a clinician. |
Patient education highlights
- HighDifferent conditions
A toe-webbing finding is not the same as a rare chromosomal syndrome.
- MediumLimited evidence
Specific symptoms and outcomes for the left condition are not established in this source.
- MediumFunction
For toe syndactyly, walking ability is an important reason to seek review.